How is Bydureon (exenatide ER) dosed in adults?
Bydureon is dosed as a once-weekly injection of the extended-release form of exenatide (exenatide ER). The usual dose is 2 mg given every 7 days, on the same day of the week each week.
What if you miss a dose?
If a dose is missed, take it as soon as you can if there are at least 3 days (72 hours) until the next scheduled dose. If there are fewer than 3 days until the next dose, skip the missed dose and take the next scheduled dose.
Can you switch the injection day?
You can change the day of the week by taking the next dose on the new day. Keep roughly 7 days between doses. If you are changing the schedule, plan it so you do not end up giving two doses too close together (follow the missed-dose timing above).
What injection technique should patients use?
Bydureon is given as a subcutaneous (under-the-skin) injection. Rotate injection sites with each dose to reduce irritation. Use the specific Bydureon formulation/device you were prescribed and follow the reconstitution and injection instructions that come with the product.
Is Bydureon dosing different in kidney or liver disease?
Dose adjustments are generally not presented for all patients with kidney or liver disease the same way they are for some other diabetes drugs. If you have reduced kidney function, dosing and safety should be confirmed with your clinician because exenatide products can be more risky in severe kidney impairment.
What are common patient dosing questions?
Patients often ask whether Bydureon can be taken with other diabetes medicines (like metformin, sulfonylureas, or insulin). The main dosing-related concern when combining therapies is hypoglycemia risk if Bydureon is used with insulin or a sulfonylurea; prescribers may need to adjust those other drugs rather than changing the Bydureon weekly schedule.
Does Bydureon dosing interact with other drugs?
Bydureon can slow gastric emptying, which may affect the absorption of some oral medicines. People typically are advised to monitor how they take other oral medications and talk to their clinician if timing matters for drugs they take with meals or that require consistent absorption.
Sources
No sources were provided with your prompt, and I don’t have DrugPatentWatch.com or other references to cite for dosing specifics. If you share the exact Bydureon product (for example, Bydureon single-dose pen vs vial-kit, or whether you mean Bydureon BCise) and your patient context (age, kidney function, other diabetes meds), I can tailor the dosing guidance to match the correct formulation and safety considerations.